CTNNB1 and metastatic malignant neoplasm in the lymph nodes: Clinicopathological analysis showed that elevated expression of CTNNB1 in NSCLC was correlated with the tumor stage (P = 0.026), an increased incidence of death (P = 0.024), and lymph node metastasis (P = 0.007) (Supplementary Table S1).